Sponsors (57)
The bill directs modest, targeted federal investments in research centers, studies, training, and outreach to improve diagnosis, treatments, and workforce capacity for rare kidney diseases, trading a relatively small but recurring increase in federal spending for potentially meaningful improvements in care—though funding limits, implementation gaps, privacy risks, and uneven geographic reach could blunt its impact without further action.
People with rare kidney diseases will see increased research into causes, diagnosis, progression, and treatments through federally supported centers, studies, and pilot programs, improving prospects for earlier diagnosis and better therapies.
Patients and families in rural and underserved communities will gain outreach, education, mental-health resources, and attention to specialist access, helping reduce barriers to diagnosis and ongoing care.
Healthcare workers and training programs will get expanded clinical education and postgraduate fellowships (with possible stipends), increasing the nephrology workforce, provider capability, and potentially workforce diversity.
Taxpayers face increased federal spending from multiple authorizations (centers, studies, fellowships, pilots) that could require offsets or divert resources from other priorities.
People in underserved and rural areas may not get widespread benefit because the $6 million/year cap and modest total authorizations may limit the number, scale, and geographic reach of funded centers and programs.
Patients may experience delays in real-world access because authorized studies and reports do not themselves change coverage or benefits—recommendations will need separate implementation actions to affect testing and treatment access.
Based on analysis of 5 sections of legislative text.
Creates NIDDK Centers, mandated studies, fellowships, and Medicare experiments to boost research, testing, awareness, training, and treatments for rare kidney diseases with FY2026–2030 funding.
Introduced February 24, 2025 by Gus Bilirakis · Last progress February 24, 2025
Creates new federal grant and research authorities to improve detection, research, training, and public awareness for rare kidney diseases. It authorizes NIDDK-funded regional Centers of Excellence, a multi-agency study on testing and care patterns, new nephrology fellowships, and Medicare experiments and a public-awareness study focused on delaying or avoiding dialysis and transplants. Provides specific authorized funding through FY2026–2030, requires studies and reports to Congress with firm deadlines, allows patient-care and outreach costs to be covered by awards, and bars the use of QALYs/DALYs or similar disability-discriminatory metrics in supported research.